Skip to main content
. Author manuscript; available in PMC: 2013 Aug 19.
Published in final edited form as: Psychosomatics. 2010 Mar-Apr;51(2):137–148. doi: 10.1176/appi.psy.51.2.137

Table 4.

Psychiatric and Substance Abuse History Among Hispanics (N=85)

5-HTTLPR Genotype

L’L’
(n=21)
L’S’
(n=35)
S’S’
(n=29)
p-value
Lifetime Anxiety Disorder (%) 12.5 12.9 8.3 0.85
Lifetime Major Depression (%) 25.0 16.1 12.5 0.58
Baseline Depressive Symptoms
  Mean (SD) BDI score 8.48 (7.7) 8.14 (7.1) 8.46 (7.5) 0.98
Baseline Severity of Depression (%) 0.46
  None (BDI<=10) 66.7 71.4 67.9
  Minimal (BDI=11–14) 19.0 8.6 7.1
  Mild (BDI=15–19) 9.5 8.6 14.3
  Moderate (BDI=20–29) 0.0 11.4 10.7
  Severe (BDI>=30) 4.8 0.0 0.0
Lifetime Alcohol Use Disorder (%) 62.5 48.4 54.2 0.65
Lifetime Drug Use Disorder (%) 50.0 38.7 37.5 0.70
Medications at Baseline (% of patients)
  Anxiolytics 14.3 5.7 0.0 0.11
  SSRIs Antidepressants 9.5 17.1 20.7 0.57
  Non-SSRIs Antidepressants 14.3 17.1 17.2 0.95